Bioiberica receives Brazil authorization for novel joint health ingredient
The hyaluronic acid-rich ingredient is scientifically supported by in six preclinical studies and five randomized clinical studies over twelve years, according to the company. In addition to hyaluronic acid, Mobilee also contains other components, including collagen and polysaccharides.
“Brazil is a key market for Bioiberica in the area of joint health, where we are already market leader with our native type II collagen, b-2Cool, thanks to the strategic partnership with our Brazilian partner, Ayalla. Together with them, we will continue to meet the needs of thousands of people who look to maintain healthy joints,” said Jaume Reguant, Director of Healthcare at Bioiberica.
Mobilee is already authorized as an ingredient for food supplements and functional foods by the main competent authorities worldwide, including the European Union (Novel Food), United States (GRAS status), Canada (medicinal supplement), Australia and New Zealand (medicinal supplement and non-traditional ingredient for use in functional foods), India (functional ingredient) and Indonesia and Taiwan (nutritional supplement).
“Mobilee is an innovative product that is naturally absorbed by the human body,” explained Dr Daniel Martínez, Head of Human Health R&D at Bioiberica. “Thanks to the synergy of its individual components - hyaluronic acid, collagen and polysaccharides - the benefits Mobilee can offer, go far beyond the advantages offered by hyaluronic acid alone. Taking just 80 mg per day for at least two months preserves joint health and muscular function.”
